Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats

British Journal of Nutrition

Volumn 91, Issue 6, 2004, Pages 857-865

  Robin, Sophie ^a   Maupoil, Véronique ^a   Laurant, Pascal ^a   Jacqueson, Alain ^b   Berthelot, Alain ^a  

^a Laboratoire de Neurosciences   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Aortic rings; Deoxycorticosterone acetate salt hypertensive rats; Homocysteine

Indexed keywords

ACETYLCHOLINE; BRADYKININ; CYSTEINE; DEOXYCORTICOSTERONE ACETATE; HOMOCYSTEINE; METHIONINE; NITROPRUSSIDE SODIUM; SODIUM CHLORIDE; CALCIUM CHLORIDE; DEOXYCORTICOSTERONE; GLUTATHIONE; NORADRENALIN; SODIUM; VASOCONSTRICTOR AGENT;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; METABOLITE; MOLECULAR INTERACTION; NONHUMAN; RAT; RAT STRAIN; STRAIN DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VASCULAR RING; VASOCONSTRICTION; VASODILATATION; ANIMAL; AORTA; BLOOD; BLOOD PRESSURE; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; ORGAN SIZE; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PRESSURE; BODY WEIGHT; BRADYKININ; CALCIUM CHLORIDE; CYSTEINE; DESOXYCORTICOSTERONE; DIETARY SUPPLEMENTS; GLUTATHIONE; HOMOCYSTEINE; HYPERTENSION; MALE; METHIONINE; NITROPRUSSIDE; NOREPINEPHRINE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; VASOCONSTRICTOR AGENTS;

EID: 3142554464     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20041116     Document Type: Article

References (19)

1. Charpiot P, Bescond A, Augier T, Chareyre C, Fraterno M, Rolland PH & Garcon D (1998) Hyperhomocysteinemia induces elastolysis in minipig arteries: structural consequences, arterial site specificity and effect of captopril-hydrochlorothiazide. Matrix Biol 17, 559-574.
2. Fiorina P, Lanfredini M, Montanari A, Peca MG, Veronelli A, Mello A, Astorri E & Craveri A (1998) Plasma homocysteine and folate are related to arterial blood pressure in type 2 diabetes mellitus. Am J Hypertens 11, 1100-1107.
3. Hanratty CG, McGrath LT, McAuley DF, Young IS & Johnston GD (2001) The effects of oral methionine and homocysteine on endothelial function. Heart 85, 326-330.
4. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR & Haynes WG (1999) Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 100, 1161-1168.
5. McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56, 111-128.
6. Majors A, Ehrhart LA & Pezacka EH (1997) Homocysteine as a risk factor for vascular disease enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 17, 2074-2081.
7. Mansoor MA, Bergmark C, Haswell SJ, Savage IF, Evans PH, Berge RK, Svardal AM & Kristensen O (2000) Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin Chem 46, 385-391.
8. Matthias D, Becker CH, Riezler R & Kindling PH (1996) Homocysteine induced arterosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis 122, 201-216.
9. Militante JD & Lombardini JB (2002) Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23, 381-393.
10. Millette E, de Champlain J & Lamontagne D (2000) Altered coronary dilatation in deoxycorticosterone acetate-salt hypertension. J Hypertens 18, 1783-1793.
11. Nakata Y, Katsuya T, Takami S, Sato N, Fu Y, Ishikawa K, Takiuchi S, Rakugi H, Miki T, Higaki J & Ogihara T (1998) Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. Am J Hypertens 11, 1019-1023.
12. Pinto Y, Buikema H, van Gilst WH, Scholtens E, van Geel PP, de Graeff PA, Wagner J & Paul M (1997) Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats. J Mol Med 75, 371-377.
13. Robin S, Maupoil V. Groubatch F, Laurant P, Jacqueson A & Berthelot A (2003) Effect of a methionine-supplemented diet on the blood pressure of Wistar-Kyoto and spontaneously hypertensive rats. Br J Nutr 89, 539-548.
14. Rolland PH, Friggi A, Barlatier A, Piquet P, Latrille V, Faye MM, Guillou J, Charpiot P, Bodard H, Ghiringhelli O, et al. (1995) Hyperhomocysteinemia-induced vascular damage in the minipig. Circulation 91, 1161-1174.
15. Stockand JD, Zeltwanger S, Bao HF, Becchetti A, Worrell RT & Eaton DC (2001) S-adenosyl-L-homocysteine hydrolase is necessary for aldosterone-induced activity of epithelial Na(+) channels. Am J Physiol Cell Physiol 281, C773-C785.
16. Sutton-Tyrrell K, Bostom A, Selhub J & Zeigler-Johnson C (1997) High homocysteine levels are independently related to isolated systolic hypertension in older adults. Circulation 96, 1745-1749.
17. Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA & Porter JM (1999) Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 29, 8-19.
18. Ungvari Z, Pacher P. Rischak K, Szollar L & Koller A (1999) Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 19, 1899-1904.
19. Yen CH & Lau YT (2002) Vascular responses in male and female hypertensive rats with hyperhomocysteinemia. Hypertension 40, 322-328.